Tumor necrosis factor genetic polymorphisms correlate with infections after renal transplantation

Transplantation

Volumn 69, Issue 5, 2000, Pages 880-884

  Sahoo, Sunati ^a   Kang, Sonya ^a   Supran, Stacey ^a   Saloman, Robert ^a   Wolfe, Hubert ^a   Freeman, Richard B ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CELL DNA; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GRAFT INFECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL;

EID: 0034654465     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200003150-00036     Document Type: Article

References (40)

1. Steffen M, Ottman OG, Moore MAS. Simultaneous production of tumor necrosis factor α and lymphotoxin by normal T cells after induction with 11-2 and anti-T3. J Immunol 1998; 140: 2621.
2. Sung S-S, Jung LKL, Walters JA, Chen W, Wang CY, Fu SM. Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J Exp Med 1988; 168: 1539.
3. Cuturi MC, Murphy M, Costa-Giomi MP, Weinman R, Perussia B, Trinchieri G. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med 1987; 165: 1581.
4. Butler B, Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987; 316: 379.
5. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematous. Proc Natl Acad Sci USA 87: 1233.
6. Molvig J, Baek L, Christensen P, et al. Endotoxin-stimulated human monocyte secretion of interleukin 1, tumor necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol 1988; 27: 705.
7. Marino MW, Dunn A, Grail D, et al. Characterization of TNF deficient mice. Proc Natl Acad Sci USA 1997; 94: 8093.
8. Waage A, Brandtzaeg P, Halstensen A, et al. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 1989; 169: 333.
9. Debts JM, Kampmeijer R, Van-der-Linden, et al. Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 1989; 17: 489.
10. Abraham E, Wunderlink R, Silverman R, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. JAMA 1995; 273: 934.
11. Fisher CJJ, Agosti JM, Opal SM, et al. Treatment of septic shock with tumor necrosis factor receptor: Fc fusion protein. N Engl J Med 1996; 334: 1697.
12. Jordan SC, Czer L, Toyoda M, et al. Serum cytokine levels in heart allograft recipients: correlation with findings on endomyocardial biopsy. J Heart Lung Transplant 1993; 12: 333.
13. Chollet-Martin S, Depoix JP, Hvass U, et al. Raised plasma levels of tumor necrosis factor in heart allograft rejection. Transplant Proc 1990; 22: 283.
14. Rolfe MW, Kunkle S, Lincoln P, et al. Lung allograft rejection: role of tumor necrosis factor-alpha and interleukin-6. Chest 1993; 103: 133S.
15. McGlaughlin PJ, Aikawa A, Davies HM, et al. Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients. Transplantation 1991; 51: 1225.
16. Dorge SE, Roux-Lombard P, Dayer JM, et al. Plasma levels of tumor necrosis factor and soluble TNF receptors in kidney transplant recipients. Transplantation 1994; 58: 1000.
17. Blancho G, Moreau JF, Ghabannes D, et al. HILDA/LDF, G-CSF, IL-1 beta, IL,-6, and TNF alpha production during acute rejection of human kidney allografts. Transplantation Proc 1993; 25: 891.
18. Imagawa DK, Millis JM, Olthoff KM, et al. The role of tumor necrosis factor in allograft rejection. Transplantation 1990; 50: 219
19. Hoffman MW, Wonigei K, Steinhoff G, et al. Production of cytokines (TNF-alpha, IL-1 beta) and endothelial cell activation in human liver allograft rejection. Transplantation 1993; 55: 329
20. Noguchi K, Yoshida Y, Yagihashi A, et al. Serum levels of interleukin-6, tumor necrosis factor-alpha, and interleukin-2 in rejection of human small bowel allografts. Transplant Proc 1992; 24: 1152
21. Gerwal H, Kotb M, Salem A, et al. Elevated tumor necrosis factor levels are predictive for pancreas allograft transplant rejection. Transplant Proc 1993; 25: 132.
22. Noronha IL, Hartley B, Cameron JS, Waldherr R. Detection of IL-1 beta and TNF-alpha message and protein in renal allograft biopsies. Transplantation 1993; 56: 1026.
23. Morel D, Normand E, Lemoine C, et al. Tumor necrosis factor-alpha in human kidney transplant rejection: analysis by in situ hybridization. Transplantation 1993; 55: 773.
24. Arbustini E, Grasso M, Diegoli M, et al. Expression of tumor necrosis factor in human cardiac rejection: an immunohistochemical and immunoblotting study. Am J Pathol 1991; 139: 709.
25. Nedwin GE, Naylor SL, Sakaguchi AY, et al. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal location. Nucleic Acids Res 1985; 13: 6361.
26. Jacob CO. Genetic variability in tumor necrosis factor production: relevance to predisposition to autoimmune diseases 1992; 4: 298
27. Wilson AG, di Giovine FS, Duff GW. Genetics of tumor necrosis factor-alpha in autoimmune, infectious, and neoplastic disease. J Inflamm 1995; 45: 1.
28. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the tumor necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353
29. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the TNF-beta gene correlates with a variant amino acid in position 26 and reduced level of TNF-beta production. J Exp Med 1991; 173: 209.
30. Piciot F, Molvig J, Wogensen L, et al. A tumor necrosis factor beta polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 1991; 33: 37.
31. Piciot F, Briant L, Jongeel CV, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes. Eur J Immunol 1993; 23: 224.
32. Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patient with severe sepsis. Crit Care Med 1996; 24: 381.
33. Freeman RB, Tran CL, Mattoli J, et al. Tumor necrosis factor genetic polymorphism correlate with infections after liver transplantation. Transplantation 1999; 67: 1005.
34. Jackson W, Konieczny B, Bray B, et al. Graft outcome following clinical kidney transplantation correlates with polymorphism of the TNF-B locus. American Society of Transplant Physicians Meeting 1993 (abstract).
35. Goeken NE, Greazel NA, Johnson MM, Hunsicker LG. TNF-B genetics and renal allograft rejection: a lesson in unexpected results and confounding variables. American Society of Transplant Physicians Meeting 1994 (abstract).
36. Mahoney RJ, Szatkowski MA, White B, Leeber DA. Tumor necrosis factor B gene polymorphism and early primary kidney allograft loss. Hum Immunol 1996; 50: 148.
37. Wilson A, Gordon C, di Giovine FS, et al. A genetic association between systemic lupus erythematous and tumor necrosis factor alpha. Eur J Immunol 1994; 24: 191.
38. Plevy SE, Targan SR, Yang H, Fernandez D, Roter JI, Toyoda H. Tumor necrosis factor microsatellites define a Chron's disease-association haplotype on chromosome 6. Gastroenterology 1996; 110: 1053.
39. Mizuki N, Ohno S, Sato T, et al. Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Beh-cet's disease. Hum Immunol 1995; 43: 129.
40. Eason JD, Wee S, Kawai T, et al. Inhibition of the effect of TNF in renal allograft recipients using recombinant human dimeric tumor necrosis factor receptors. Transplantation 1995; 59(2): 300.